← Back to headlines
Alvotech Receives FDA Form 483 Following Facility Inspection
Biopharmaceutical company Alvotech has received an FDA Form 483 after a routine facility inspection, indicating observations of potential violations.
6 Jun, 15:44 — 6 Jun, 15:44
Sources
Showing 1 of 1 sources
Related Stories
Companies Launch Back-to-School Promotions and Corporate Initiatives Across Region
23m ago
Eurozone Joblessness Data Shows Diverging National Employment Trends
23m ago
Eurozone Inflation Surges to Three-Year High of 3.3 Percent
33m ago
Shein Shares Fall on Hong Kong Debut as France Imposes Fast Fashion Levies
47m ago